Treatment of venous thromboembolism with low-molecular-weight heparin

A synthesis of the evidence published in systematic literature reviews

J. A. Krishnan, J. B. Segal, M. B. Streiff, D. T. Bolger, J. Eng, M. W. Jenckes, Leonardo Tamariz, E. B. Bass

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: To evaluate the methodology and cumulative evidence presented in systematic reviews of clinical trials comparing low-molecular-weight heparin (LMWH) with unfractionated heparin (UFH) for the treatment of venous thromboembolism. Methods: We reviewed all systematic reviews of clinical trials published until March 2002. Fourteen systematic literature reviews were published between 1994 and 2000. Deficiencies in methodological quality were common, particularly in the description of search strategies, assessment of clinical trial quality, and methods used to combine results. Results: Results of reviews indicate that LMWH is superior to UFH for the treatment of venous thromboembolism, particularly in reducing mortality. Patients with isolated deep venous thrombosis or deep venous thrombosis with concomitant pulmonary embolism seemed to have similar benefit. However, the benefits of LMWH over UFH were smaller in magnitude in reviews that included more recent clinical trials.

Original languageEnglish
Pages (from-to)376-386
Number of pages11
JournalRespiratory Medicine
Volume98
Issue number5
DOIs
StatePublished - May 1 2004
Externally publishedYes

Fingerprint

Low Molecular Weight Heparin
Venous Thromboembolism
Clinical Trials
Heparin
Venous Thrombosis
Therapeutics
Pulmonary Embolism
Mortality

Keywords

  • Low-molecular-weight heparin
  • Systematic reviews
  • Unfractionated heparin
  • Venous thromboembolism

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Treatment of venous thromboembolism with low-molecular-weight heparin : A synthesis of the evidence published in systematic literature reviews. / Krishnan, J. A.; Segal, J. B.; Streiff, M. B.; Bolger, D. T.; Eng, J.; Jenckes, M. W.; Tamariz, Leonardo; Bass, E. B.

In: Respiratory Medicine, Vol. 98, No. 5, 01.05.2004, p. 376-386.

Research output: Contribution to journalArticle

Krishnan, J. A. ; Segal, J. B. ; Streiff, M. B. ; Bolger, D. T. ; Eng, J. ; Jenckes, M. W. ; Tamariz, Leonardo ; Bass, E. B. / Treatment of venous thromboembolism with low-molecular-weight heparin : A synthesis of the evidence published in systematic literature reviews. In: Respiratory Medicine. 2004 ; Vol. 98, No. 5. pp. 376-386.
@article{baeeb0bcb13549e182885beb758aca3d,
title = "Treatment of venous thromboembolism with low-molecular-weight heparin: A synthesis of the evidence published in systematic literature reviews",
abstract = "Objective: To evaluate the methodology and cumulative evidence presented in systematic reviews of clinical trials comparing low-molecular-weight heparin (LMWH) with unfractionated heparin (UFH) for the treatment of venous thromboembolism. Methods: We reviewed all systematic reviews of clinical trials published until March 2002. Fourteen systematic literature reviews were published between 1994 and 2000. Deficiencies in methodological quality were common, particularly in the description of search strategies, assessment of clinical trial quality, and methods used to combine results. Results: Results of reviews indicate that LMWH is superior to UFH for the treatment of venous thromboembolism, particularly in reducing mortality. Patients with isolated deep venous thrombosis or deep venous thrombosis with concomitant pulmonary embolism seemed to have similar benefit. However, the benefits of LMWH over UFH were smaller in magnitude in reviews that included more recent clinical trials.",
keywords = "Low-molecular-weight heparin, Systematic reviews, Unfractionated heparin, Venous thromboembolism",
author = "Krishnan, {J. A.} and Segal, {J. B.} and Streiff, {M. B.} and Bolger, {D. T.} and J. Eng and Jenckes, {M. W.} and Leonardo Tamariz and Bass, {E. B.}",
year = "2004",
month = "5",
day = "1",
doi = "10.1016/j.rmed.2004.02.017",
language = "English",
volume = "98",
pages = "376--386",
journal = "Respiratory Medicine",
issn = "0954-6111",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Treatment of venous thromboembolism with low-molecular-weight heparin

T2 - A synthesis of the evidence published in systematic literature reviews

AU - Krishnan, J. A.

AU - Segal, J. B.

AU - Streiff, M. B.

AU - Bolger, D. T.

AU - Eng, J.

AU - Jenckes, M. W.

AU - Tamariz, Leonardo

AU - Bass, E. B.

PY - 2004/5/1

Y1 - 2004/5/1

N2 - Objective: To evaluate the methodology and cumulative evidence presented in systematic reviews of clinical trials comparing low-molecular-weight heparin (LMWH) with unfractionated heparin (UFH) for the treatment of venous thromboembolism. Methods: We reviewed all systematic reviews of clinical trials published until March 2002. Fourteen systematic literature reviews were published between 1994 and 2000. Deficiencies in methodological quality were common, particularly in the description of search strategies, assessment of clinical trial quality, and methods used to combine results. Results: Results of reviews indicate that LMWH is superior to UFH for the treatment of venous thromboembolism, particularly in reducing mortality. Patients with isolated deep venous thrombosis or deep venous thrombosis with concomitant pulmonary embolism seemed to have similar benefit. However, the benefits of LMWH over UFH were smaller in magnitude in reviews that included more recent clinical trials.

AB - Objective: To evaluate the methodology and cumulative evidence presented in systematic reviews of clinical trials comparing low-molecular-weight heparin (LMWH) with unfractionated heparin (UFH) for the treatment of venous thromboembolism. Methods: We reviewed all systematic reviews of clinical trials published until March 2002. Fourteen systematic literature reviews were published between 1994 and 2000. Deficiencies in methodological quality were common, particularly in the description of search strategies, assessment of clinical trial quality, and methods used to combine results. Results: Results of reviews indicate that LMWH is superior to UFH for the treatment of venous thromboembolism, particularly in reducing mortality. Patients with isolated deep venous thrombosis or deep venous thrombosis with concomitant pulmonary embolism seemed to have similar benefit. However, the benefits of LMWH over UFH were smaller in magnitude in reviews that included more recent clinical trials.

KW - Low-molecular-weight heparin

KW - Systematic reviews

KW - Unfractionated heparin

KW - Venous thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=2342621534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342621534&partnerID=8YFLogxK

U2 - 10.1016/j.rmed.2004.02.017

DO - 10.1016/j.rmed.2004.02.017

M3 - Article

VL - 98

SP - 376

EP - 386

JO - Respiratory Medicine

JF - Respiratory Medicine

SN - 0954-6111

IS - 5

ER -